Cryo-Cell International, Inc.
| Security | CCEL / Cryo-Cell International, Inc. |
| Insider | Jill M Taymans |
This page shows the track record and history of TAYMANS JILL M
insider trades in Cryo-Cell International, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Jill M Taymans in CCEL / Cryo-Cell International, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Jill M Taymans in CCEL / Cryo-Cell International, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | 2026-05-28 | 4 | TAYMANS JILL M | CCEL | Common Stock | D | 3.1000 | 7,500 | 23 | 52,896 | ||||
| 2020-09-25 | 2020-09-23 | 4 | TAYMANS JILL M | CCEL | Stock Option | D | 8.00 | 8.0000 | 7,000 | 56 | 7,000 | |||
| 2017-02-06 | 2017-02-01 | 4 | TAYMANS JILL M | CCEL | Stock Option | D | 1.50 | 1.5000 | -9,281 | -14 | 0 | |||
| 2017-02-06 | 2017-02-01 | 4 | TAYMANS JILL M | CCEL | Common Stock | D | 1.5000 | 9,281 | 14 | 45,396 | ||||
| 2017-02-06 | 2016-06-02 | 4 | TAYMANS JILL M | CCEL | Stock Option | D | 3.10 | 3.1000 | 7,500 | 23 | 7,500 | |||
| 2016-08-17 | 2016-08-03 | 4 | TAYMANS JILL M | CCEL | Stock Option | D | 1.73 | 1.7300 | -18,563 | -32 | 0 | |||
| 2016-08-17 | 2016-08-03 | 4 | TAYMANS JILL M | CCEL | Common Stock | D | 1.7300 | 18,563 | 32 | 36,115 | ||||
| 2016-08-17 | 2016-06-02 | 4 | TAYMANS JILL M | CCEL | Stock Option | D | 3.10 | 3.1000 | 7,500 | 23 | 7,500 |
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)
